aiomics, a company focused on transforming healthcare information flow, has raised $250,000 in a recent funding round. The capital infusion will support the company's mission to address the challenges posed by unstructured data within European healthcare systems, aiming to convert fragmented medical information into actionable intelligence.
The company is developing an EU-compliant AI backbone designed to alleviate administrative burdens and provide clinical insight. Its initial offering includes AI assistants that streamline documentation for healthcare professionals, freeing up time currently spent on administrative tasks, and empowers patients with contextual access to their health information. This approach directly responds to the projected shortage of healthcare workers by 2030 and the significant time clinicians spend on documentation rather than direct patient care.
This funding round provides aiomics with essential capital to advance its intelligent infrastructure, which it terms the "Care Triad." The company plans to use the funds for growth initiatives, including the continued development of its platform that connects providers, patients, and data through intuitive AI interfaces. This investment underscores investor confidence in aiomics' solution to a critical problem in the European healthcare sector.
aiomics has already demonstrated early traction, co-developing its foundational infrastructure with pilot customers across various healthcare settings, including telemedicine, rehabilitation clinics, general practice, and MedTech manufacturing. The company is positioned to scale its innovative approach, enabling the next generation of efficient and informed healthcare delivery across Europe.
